Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 6.5B | 6.3B | 6.5B | 5.8B |
Cost of revenue | 3.9B | 3.2B | 3.2B | 2.9B |
Gross profit | 2.6B | 3.2B | 3.3B | 2.9B |
Operating expense | ||||
Research & development | 1.6B | 1.5B | 1.5B | 1.4B |
Selling general and admin | 844.6M | 755.1M | 675.0M | 614.5M |
Other operating expenses | — | — | -9.4M | -11.9M |
Operating income | -114.2M | 687.0M | 900.9M | 617.1M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 32.4M | 17.0M | 16.2M | 19.6M |
Other income expense | 83.5M | 33.2M | -282.1M | 30.7M |
Pretax income | -63.1M | 703.1M | 757.7M | 628.1M |
Tax provision | -710.8M | 104.8M | 357.1M | -23.0M |
Net income | 743.2M | 604.3M | 410.8M | 657.1M |
Basic EPS | 0.5 | 0.4 | 0.3 | 0.5 |
Diluted EPS | 0.5 | 0.4 | 0.3 | 0.5 |
Basic average shares | 1.4B | 1.4B | 1.4B | 1.4B |
Diluted average shares | 1.4B | 1.4B | 1.4B | 1.4B |
EBITDA | 614.5M | 1.4B | 1.4B | 1.4B |
Net income from continuing op. | 654.6M | 604.3M | 410.8M | 657.1M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |